UPDATE: Laidlaw Starts Evofem Biosciences Inc (EVFM) at Buy, 'A Novel Niche Contraceptive with Sales Likely to Take off in 2022 and Beyond'
Tweet Send to a Friend
(Updated - June 2, 2022 6:17 AM EDT)
Laidlaw analyst Yale Jen initiates coverage on Evofem Biosciences Inc (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Laidlaw analyst Yale Jen initiates coverage on Evofem Biosciences Inc (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
